Positive study shows potential of higher dose nusinersen to improve SMA treatment
Biogen's Phase 2/3 study showed a higher dose of nusinersen improves motor function in SMA infants, with plans for regulatory submission to advance treatment.
Food Insecurity and the Dangers of Infant Formula Dilution
Metabolic profiles could help identify infants at higher risk for SIDS
Findings from a newly-published study revealed that newborn metabolic profiles may identify infants at an increased risk for SIDS shortly after birth.
Demystifying Infant Formula
A discussion of pediatric growth hormone deficiency with Andrew Dauber, MD, MMSc
Andrew Dauber, MD, MMSc, of Children's National Hospital joined us to talk PGHD and the role of the pediatrician when it comes to treatment.
Diffuse targetoid and bullous skin lesions, mucositis, and ocular discharge in an adolescent male
Can you diagnose this adolescent with an 11-day history of diffuse targetoid and bullous lesions on his extremities and trunk?
